Bailard Inc. Makes New $531,000 Investment in Privia Health Group, Inc. $PRVA

Bailard Inc. acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 23,100 shares of the company’s stock, valued at approximately $531,000.

Several other institutional investors have also recently added to or reduced their stakes in PRVA. CWM LLC boosted its stake in Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after buying an additional 604 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after acquiring an additional 2,567 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Privia Health Group by 2,115.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock worth $75,000 after acquiring an additional 3,173 shares during the period. Vestcor Inc acquired a new stake in shares of Privia Health Group in the first quarter worth approximately $76,000. Finally, Financiere des Professionnels Fonds d investissement inc. acquired a new stake in shares of Privia Health Group in the second quarter worth approximately $153,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Canaccord Genuity Group increased their price target on shares of Privia Health Group from $32.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday. Stephens restated an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a report on Wednesday, September 24th. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a report on Thursday. JMP Securities boosted their price target on Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday, August 29th. Finally, Truist Financial restated a “buy” rating and set a $31.00 price target (up from $30.00) on shares of Privia Health Group in a research note on Monday, November 10th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $30.00.

Privia Health Group Trading Down 1.3%

Shares of NASDAQ PRVA opened at $23.45 on Friday. Privia Health Group, Inc. has a 12-month low of $18.77 and a 12-month high of $26.51. The company has a market cap of $2.88 billion, a P/E ratio of 180.40, a P/E/G ratio of 3.96 and a beta of 0.83. The stock has a fifty day moving average price of $24.21 and a 200 day moving average price of $22.79.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%.The company had revenue of $213.61 million for the quarter. On average, sell-side analysts forecast that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.